If you've been told you have osteoporosis or are at high risk of a fracture, treatment can meaningfully lower the odds of a broken bone. The goal isn't to chase a perfect scan score — it's to keep you mobile and out of the hospital.
The goal of osteoporosis treatment: fewer fractures, not a perfect number
It's tempting to fixate on your bone-density score, but the real aim of treatment is reducing fracture risk — especially fractures of the hip and spine, which can be life-changing. Two people with the same score may need very different plans depending on age, fracture history, and other factors. So when we talk about how to treat osteoporosis, think in terms of risk reduction over time, not a single number on a report.
Foundations everyone needs
Before and alongside any medication, a few basics support bone strength and prevent falls. These help almost everyone, whether or not you take a drug.
- Adequate calcium and vitamin D. Calcium is best obtained from food, and more is not better. As general guidance, many adults aim for roughly 1,000–1,200 mg of calcium a day (the higher end for women over 50), and around 600–800 IU of vitamin D a day — figures to individualize with a clinician, not a prescription. There's genuine debate about whether high-dose calcium supplements modestly affect heart risk, so food first is the sensible default. Vitamin D helps those who are deficient or get little sun, but mega-dosing won't build extra bone and very high doses can be harmful, raising blood calcium to toxic levels. See our guide to calcium and vitamin D for bones and the vitamin D glossary entry.
- Weight-bearing and strength exercise. Activity helps maintain bone and, crucially, improves balance to prevent falls. It won't reverse established osteoporosis on its own, and some high-impact or deep spine-flexion moves can be unsafe for fragile spines — get individualized guidance. See exercises for bone density.
- Not smoking and limiting alcohol. Both weaken bone and raise fracture risk.
- Fall prevention. Good lighting, removing trip hazards, vision checks, and reviewing medications that cause dizziness all matter, because most fractures follow a fall.
How treatment decisions use fracture risk
Diagnosis is made by a bone-density (DEXA) test, not by symptoms. The result is reported as a T-score, often combined with a risk calculator such as FRAX, which estimates your 10-year chance of a major fracture using age, prior fractures, and other factors.
| T-score | Category | General implication |
|---|---|---|
| −1.0 and above | Normal bone density | Focus on foundations |
| −1.0 to −2.5 | Osteopenia (low bone mass) | Often no medication; reassess risk |
| −2.5 and below | Osteoporosis | Medication often considered |
Importantly, osteopenia is not a disease and not a guarantee of osteoporosis — most people with it don't need medication. Decisions also weigh FRAX scores and any past fragility fracture, which alone can prompt treatment. In fact, medication is sometimes considered even with an osteopenia-range T-score when a person's FRAX 10-year risk crosses commonly used thresholds (for example, a high estimated risk of hip or major fracture), because the calculator captures risks the score alone misses.
Osteoporosis medications, explained (not prescribed)
The descriptions below are educational. Which medication fits you — if any — is a clinician decision based on your individual risk, kidney function, and preferences.
Bisphosphonates (often first-line)
Bisphosphonates slow the cells that break down bone. Oral options such as alendronate (weekly) and risedronate, and intravenous options like zoledronic acid (yearly), are common, well-studied first choices that reduce hip and spine fractures.
Denosumab
An injection given under the skin twice a year that also slows bone breakdown. It can suit people who can't take bisphosphonates — for instance, those with reduced kidney function. One practical caveat is important: denosumab must not be stopped abruptly without a follow-on plan. When it's discontinued, its protective effect fades quickly and bone loss can rebound, sometimes with a burst of rapid loss and even spine fractures, so clinicians typically transition to another medication rather than simply stopping.
Bone-building (anabolic) agents
For people at very high risk — for example, after a recent spine fracture or with very low density — anabolic agents (such as teriparatide or romosozumab) actively build new bone and are typically used for a limited period, then followed by another medication to hold the gains. Romosozumab carries an added caution: it is generally avoided in people with recent or high cardiovascular risk (it is not used within a year of a heart attack or stroke), so the choice is weighed carefully against heart history.
Hormone-related options around menopause
This is where the menopause connection matters. Estrogen protects bone, so its decline at menopause speeds bone loss — a major reason osteoporosis is more common in women. (See menopause and bone loss.) For some women around the menopause transition, menopausal hormone therapy can help protect bone while also easing symptoms; it's individualized, weighing benefits and risks. Our overview of menopause treatment options covers this in depth. Raloxifene, a selective estrogen receptor modulator, is another option that can reduce spine fractures.
Bisphosphonate safety, in proportion
Bisphosphonates are generally well tolerated and effective at preventing fractures. The most common issues are mild — heartburn or stomach upset with oral forms, or flu-like symptoms after the first IV dose. Two rare side effects are worth knowing about honestly:
- Osteonecrosis of the jaw — uncommon, more often linked to high-dose use and dental procedures.
- Atypical femur (thigh-bone) fracture — rare, sometimes preceded by aching thigh or groin pain.
For people who genuinely need treatment, the benefit of preventing common, serious fractures usually outweighs these rare risks. To balance them, clinicians often review oral bisphosphonate treatment after about five years (or three years for the yearly IV form) and may pause therapy — a "drug holiday" — in lower-risk people, while continuing in those who remain at high risk. Either way, a clinician will usually recheck a DEXA scan periodically to see how bone density is holding and guide the next step. Don't start or stop on your own.
When to see a clinician
Treatment is individualized, so partner with a clinician rather than self-managing. Seek advice if you:
- Have had a fragility fracture (a break from a minor fall or knock).
- Are approaching or past menopause and want to understand your risk — see menopause age and perimenopause symptoms.
- Are taking bone medication and notice new thigh, hip, or jaw pain, or need dental surgery — report these promptly.
- Want to know whether your osteopenia or osteoporosis warrants medication, or whether a drug holiday is appropriate.
Never start or stop a bone medication on your own. This article is educational and not a substitute for personalized medical advice.
